Heather Dixon supports Acadia Healthcare’s ambitious long-term growth vision while managing near-term financial performance. CEO Chris Hunter set a mandate in 2022 to double the company’s revenue by 2028, requiring sustained growth across multiple strategic initiatives.
Dixon has maintained focus on this long-term objective despite near-term headwinds. “Nothing has changed with how we’re thinking about the opportunity here,” Heather Dixon stated regarding the company’s long-term outlook. “The strategy that we have in terms of meeting that significant unmet demand is the same. We’ll continue to expand capacity and continue to meet that need.”
Acadia Healthcare’s revenue reached $3.15 billion in 2024, representing 7.7% growth compared to the prior year. The company’s revenue streams reflect diverse payer relationships: 57% from Medicaid, 26% from commercial insurance, 14% from Medicare, and 3% from self-pay and other sources as of the first nine months of 2024.
For the years following 2025, Dixon projects revenue growth of 7% to 9% annually, with EBITDA growth of 8% to 10%. The differential between these growth rates indicates expected margin expansion as facilities mature and startup costs decline. “We would expect 2026 to be at the high end of that range based on all the things that I just talked to,” Dixon explained during investor discussions.
Volume growth represents a key driver of future financial performance. Heather Dixon expects volume growth in the mid-single digit range on average, incorporating new bed additions and organic growth at existing facilities. This projection reflects both the maturation of recently opened beds and continued market demand for behavioral health services.
Pricing assumptions remain conservative within Dixon’s financial projections. Acadia Healthcare expects low single-digit pricing growth for 2025, reflecting a moderation from historical levels. Factors influencing pricing include Medicaid reimbursement rates, commercial payer negotiations, and supplemental payment timing.
Supplemental payments from government programs represent an area requiring careful financial management. Dixon noted that supplemental payment timing created approximately $10 million to $15 million of impact in the first quarter of 2025 compared to the prior year. For full-year 2025, Acadia Healthcare guidance assumes supplemental payments will be flat to up $15 million.
Capital allocation strategy balances multiple priorities under Dixon’s financial leadership. The company must fund ongoing facility development, support operational needs, maintain appropriate leverage levels, and consider opportunities for strategic acquisitions or capital returns. Dixon emphasized the importance of maintaining financial flexibility as bed additions moderate and cash flow improves.
Heather Dixon’s approach incorporates risk management alongside growth pursuit. The company maintains insurance reserves for professional liability and workers’ compensation exposures. Dixon noted that Acadia Healthcare added $10 million to insurance reserves in 2025 on top of $14 million added in 2024, reflecting actuarial assessments of potential claims.